Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ORIYOMI OMOTOYOSI AKINYOTU
With
University of Ibadan
This study is intended to be a randomized controlled single blind prospective comparative study conducted to compare the efficacy of three, monthly doses of sulphadoxine-pyrimethamine as intermittent preventive therapy with Mefloquine as-intermittent preventive therapy in HIV-infected pregnant women.
Age
18–45
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Pregnant HIV positive patients
Gestational age 16 weeks and above
No history of use of Mefloquine or Sulphadoxine
Pyrimethamine four weeks prior to recruitment.
You may not be if
Anaemia packed cell volume less than 30%
Pre -existing medical conditions- Diabetes Mellitus, -Hypertension
Allergy to Sulphadoxine- Pyrimethamine or Mefloquine
